Fierce Health Payers May 6, 2020
Wearables giant Fitbit launched a sweeping heart study on Wednesday aimed at exploring whether its devices can detect atrial fibrillation.
It’s part of Fitbit’s broader ambitions in healthcare to use its wearable technology for preventive health to reduce the risk of life-threatening events like stroke by detecting problems earlier.
With the launch of the heart study, Fitbit is chasing down competitor Apple which received FDA clearance in 2018 for its ECG feature and more recently launched a study with Johnson & Johnson to explore whether its own wearables can detect Afib.
“Wearable data and the kinds of information wearable data can provide will serve as another tier in the healthcare system,” Eric Friedman, Fitbit co-founder and chief technology...
Today's Sponsors
Today's Sponsor